Takeda Pharmaceutical Company Limited (TAK)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Takeda Pharmaceutical Company Limited (TAK) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $60.52B, a trailing price-to-earnings ratio of 37.9 and a free-cash-flow yield of 6.6%. Over the most recent reported fiscal year, revenue declined 1.7% and free cash flow per share fell 7.3%.

Market cap	$60.52B
Trailing P/E	37.9
FCF yield	6.6%
Revenue growth (YoY)	-1.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	-7.3%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live TAK data on Nama Insights →

Recent Congressional trades

Takeda Pharmaceutical Company Limited trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Virginia Foxx	House	Sell	$15,001 - $50,000	Sep 5, 2023
Daniel Goldman	House	Sell	$15,001 - $50,000	Aug 13, 2023